always treat the manufacturer label and documentation as the primary reference for the specific vial in your possession
Let's collaborate to advance your research and development efforts
Nevertheless, another study (Ke et al., 2009) showed that c-Met was not an independent prognostic factor of HCC for OS and cumulative recurrence, but the combination of c-Met/CD151 was
Wash your hands before handling the vial or removing the cap
In some embodiments, the otic formulation or composition comprises between about 0.001% to about 10% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof
Pulmonary Thromboembolism Model Lung Histology Middle Cerebral Artery Occlusion Model Neurological Scoring Measurement of Infarct Volume Pharmacological Interventions in the Middle Cerebral Artery Occlusion Model 5,6 intraperitoneally 30 minutes before the MCAO ischemia/reperfusion procedure